Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

被引：0

作者：

Charles M Fogarty

Tushar C Patel

Lala M Dunbar

Bruno P Leroy

机构：

[1] Spartanburg Medical Research,Department of Medicine/Emergency Medicine

[2] Fall River Walk-in Clinic,undefined

[3] Louisiana State University Medical Center,undefined

[4] Aventis Pharmaceuticals,undefined

来源：

BMC Infectious Diseases | / 5卷

关键词：

Minimum Inhibitory Concentration; Clinical Cure; Eradication Rate; Causative Pathogen; mITT Population;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study
Fogarty, CM
Patel, TC
Dunbar, LM
Leroy, BP
[J]. BMC INFECTIOUS DISEASES, 2005, 5 (1)
[2] Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia
Carbon, C
Moola, S
Velancsics, I
Leroy, B
Rangaraju, M
Decosta, P
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) : 691 - 703
[3] Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days
Paris, R.
Confalonieri, M.
Dal Negro, R.
Ligia, G. P.
Mos, L.
Rastelli, V.
Perna, G.
Cepparulo, M.
[J]. JOURNAL OF CHEMOTHERAPY, 2008, 20 (01) : 77 - 86
[4] Efficacy and safety of telithromycin in community-acquired pneumonia
Van Rensburg, DJ
Matthews, PA
Leroy, B
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (07) : 397 - 400
[5] Telithromycin, a once daily dosed ketolide for the treatment of community-acquired pneumonia
Carbon, C
[J]. PRESSE MEDICALE, 2000, 29 (37): : 2042 - 2043
[6] Efficacy and safety of grepafloxacin 600 mg daily for 10 days in patients with community-acquired pneumonia
Topkis, S
Swarz, H
Breisch, SA
Maroli, AN
[J]. CLINICAL THERAPEUTICS, 1997, 19 (05) : 975 - 988
[7] Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia
Patel, T
Pearl, J
Williams, J
Haverstock, D
Church, D
[J]. RESPIRATORY MEDICINE, 2000, 94 (02) : 97 - 105
[8] Efficacy of once daily gemifloxacin in the treatment of community-acquired pneumonia
File, TM
Schlemmer, B
Garau, J
Siquier, B
Hendrick, K
Young, C
[J]. CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 241 - 241
[9] Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults
Dunbar, LM
Hassman, J
Tellier, G
[J]. CLINICAL THERAPEUTICS, 2004, 26 (01) : 48 - 62
[10] Efficacy and safety of intravenous sulbactam/ampicillin 3 g 4 times daily in Japanese adults with moderate to severe community-acquired pneumonia: A multicenter, open-label, uncontrolled study
Kohno, Shigeru
Tateda, Kazuhiro
Mikamo, Hiroshige
Kadota, Jun-ichi
Niki, Yoshihito
Itamura, Rio
[J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (3-4) : 182 - 188

← 1 2 3 4 5 →